Differential
diagnosis of the functional and organic diseases of intestine in children.
IRRITABLE
BOWEL SYNDROME IN CHILDREN
Irritable bowel syndrome (IBS) is
a digestive disorder that causes abdominal pain, bloating, gas, diarrhoea, and
constipation—or some combination of these problems. IBS affects people of all
ages, including children.
IBS is classified as a functional
disorder because it is caused by a problem in how the intestines, or bowels,
work. People with IBS tend to have overly sensitive intestines that have muscle
spasms in response to food, gas, and sometimes stress. These spasms may cause
pain, diarrhoea, and constipation.
Risk Factors for Irritable Bowel Syndrome
Symptoms of IBS cannot be
traced to a single organic cause. Research suggests that people with IBS seem
to have a colon that is more sensitive and reactive than usual to a variety of
things, including certain foods and stress. Some evidence indicates that the
immune system, which fights infection, is also involved. IBS symptoms can
result from the following:
·
The normal motility of the colon may
not work properly. It can be spasmodic or can even stop temporarily. Spasms are
sudden strong muscle contractions that come and go.
·
The lining of the colon (epithelium),
which is affected by the immune and nervous systems, regulates the passage of
fluids in and out of the colon. In IBS, the epithelium appears to work
properly. However, fast movement of the colon's contents can overcome the
absorptive capacity of the colon. The result is too much fluid in the stool. In
other patients, colonic movement is too slow, too much fluid is absorbed, and
constipation develops.
·
The colon responds strongly to
stimuli (for example, foods or stress) that would not bother most people.
Progression of Irritable Bowel Syndrome
The natural history of IBS is
unclear, and generally consists of repeated episodes of intestinal symptoms,
which makes initiation of treatment plans difficult.
Causes of IBS
The cause of IBS is
unknown. Research suggests people with IBS are more sensitive to gas or stool
in the colon. People with IBS can also have abnormalities in how their
intestines contract, called motility, which refers to the rate stool moves
through the intestines. Whereas a faster rate of movement may cause diarrhea, a slower rate may result in constipation.
Researchers have proposed
many explanations for the increased bowel sensitivity and abnormal bowel
motility associated with IBS, such as
Ø reactions
to certain foods
Ø overgrowth
of bacteria in the colon
Ø psychological
stress, including anxiety and depression
Ø problems
in the way the brain and the gastrointestinal tract communicate with each
other, called the brain-gut connection
IBS may be a cause of recurring
abdominal pain in children. The diagnosis of IBS is based on having abdominal
pain or discomfort plus any two of the following:
The
pain is relieved by having a bowel movement.
The onset of pain is associated with a
change in the frequency of stools.
The
onset of pain is associated with a change in stool consistency.
The symptoms must be present for at
least 12 weeks in the preceding 12 months, and there should be no diseases that
might cause the symptoms.
In children IBS affects girls and
boys equally and may be diarrhoea-predominant, constipation-predominant, or
have a variable stool pattern.
Children with IBS may also have headache,
nausea, or mucus in the stool. Weight loss may occur if a child eats less to
try to avoid pain. Some children first develop symptoms after a stressful
event, such as teething, a bout with the flu, or problems at school or at home.
Stress does not cause IBS, but it can trigger symptoms.
The frequency and severity of IBS symptoms vary widely and may include:
abdominal
pain or discomfort
intestinal
bloating
irregular
bowel habits, including diarrhea, constipation, or
both
a
change in the appearance of stool, including stools that are loose, hard, thin,
or pelletlike
mucus
in the stool
the
need to strain to have a bowel movement
a
sense of urgency when having a bowel movement
the
sensation of not completely emptying the bowels
Diagnostics
IBS is diagnosed based on
symptoms. A diagnostic manual called Rome III guides doctors in diagnosing and
treating functional gastrointestinal disorders, including IBS. According to
Rome III, for a child to be diagnosed with IBS, abdominal pain or discomfort
must be present at least 1 day per week for a period of 2 months or longer. Two
or more of the following must also occur at least 25 percent of the time:
Ø The
pain or discomfort is relieved by having a bowel movement.
Ø The
pain or discomfort is associated with an increase or decrease in the number of
bowel movements.
Ø The
pain or discomfort is associated with a change in the appearance of stool.
No test can show if a person
has IBS; however, a doctor may run tests to rule out diseases with symptoms
similar to IBS. Signs and symptoms that suggest a problem other than IBS
include:
·
persistent pain in the upper right or
lower right area of the abdomen
·
difficulty swallowing
·
persistent vomiting
·
gastrointestinal bleeding
·
waking up during the night with diarrhea or because of abdominal pain
·
a family history of IBD, celiac
disease, or peptic ulcer disease
·
arthritis
·
inflamed, pus-filled masses around
the rectum, also called perirectal disease
·
involuntary weight loss
·
a sudden stop in height growth
·
delayed puberty
·
unexplained fever
To diagnose IBS, the doctor
will ask questions about symptoms and examine the child to rule out more
serious problems or diseases. IBS is not a disease—it is a syndrome, or group
of symptoms that occur together. It does not damage the intestine, so if the
physical exam and other tests show no sign of disease or damage, the doctor may
diagnose IBS.
Treatment
No cure for
IBS exists; however, treatment can reduce symptoms. Treatment is guided by the
symptoms present, their severity, and the child’s response to treatment.
Treatment includes dietary changes, medication, and stress management.
Dietary Changes
Being
a chronic gastrointestinal disorder, irritable bowel syndrome (IBS) is closely
connected with the food we eat, and the way we eat it. This is why diet plays a
very important role in alleviating or aggravating IBS. For the gut to properly
function in digesting and moving waste material, a diet, modified according to
the needs of the sufferer must be followed. Several food categories and methods
of eating are more beneficial and are included in any recommended diet for
irritable bowel syndrome sufferers.
Reducing
or eliminating certain foods may improve symptoms. Common trigger foods include
fatty foods, dairy products, carbonated beverages, and caffeine. Keeping a
diary of symptoms, bowel habits, and diet may help identify foods that trigger
IBS symptoms.
Eating high-fiber foods, such as fruits, vegetables, and whole grain
breads and cereals, may also help. Fiber helps
relieve constipation and promotes regular bowel movements.
Eating several small
meals throughout the day instead of a few large ones may reduce symptoms.
Medications to Control
Constipation and Diarrhea
Fiber
supplements, such as Metamucil or Citrucil, help
control constipation.
Laxatives,
such as PEG 3350 (MiraLax, GlycoLax),
mineral oil, or bisacodyl (Dulcolax),
relieve moderate to severe constipation.
Loperamide (Imodium)
and bismuth subsalicylate (Pepto-Bismol) help relieve diarrhea.
Restores the physiological balance of bowel
movements through:
Þ lowering
the risk of constipation
Þ improvement
of intestinal microflora
Þ improvement
of the condition of intestinal epithelium
Þ improvement
of the intestinal function
Antispasmodics,
such as dycyclomine (Bentyl),
relax smooth muscle contractions in the bowel and can, theoretically, lessen
pain related to IBS but should be used with caution due to potentially serious
side effects.
Antidepressants, including
selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants
(TCAs), are used to treat IBS, although their effectiveness in children is not
well documented.
Before taking any of these
medications, children and their parents should seek the advice of a health care
provider to help weigh the potential benefits against the risk of possible side
effects.
Stress
Management
Understanding
that IBS is not a life-threatening disease can help reduce a child’s anxiety,
which may in turn lessen IBS symptoms. Certain types of counseling,
including cognitive behavior therapy and
hypnotherapy, have been shown to help manage IBS symptoms. Parents can help
reduce a child’s stress by discussing potential IBS-related issues with school
personnel—for example, the need for ready access to a private restroom.
Functional abdominal pains
Chronic functional
abdominal pain (CFAP) is the ongoing presence of abdominal pain for which there
is no known medical explanation. It is quite similar to, but less common than,
irritable bowel syndrome (IBS), and many of the same treatments for IBS can
also be of benefit to those with CFAP. The fundamental difference between IBS
and CFAP is that in CFAP, unlike in IBS, there is no change in bowel habits
such as constipation or diarrhea. Bowel dysfunction
is a necessary diagnostic criteria of IBS.
CFAP is characterized by chronic
pain with no physical explanation or findings (no structural, infectious, or
mechanical causes can be found). It is theorized that CFAP is a disorder of the
nervous system where normal nociceptive nerve impulses are amplified "like
a stereo system turned up too loud" resulting in pain. Alternately it is
hypothesized that there exists in the intestine a protozoan (namely blastocystis) which is interacting with the sympathetic
nervous system and causing the pain. Newer semi-synthetic antibiotics such as rifaximin have been used in treatment. This visceral
hypersensitivity may be a stand-alone cause of CFAP, or CFAP may result from
the same type of brain-gut nervous system disorder that underlies IBS. As with
IBS, low doses of antidepressants have been found useful in controlling the
pain of CFAP.
Abdominal pain that cannot be
explained by any visible or detectable abnormality, after a thorough physical
examination and appropriate further testing if needed, is known as functional
abdominal pain. Functional abdominal pain can be intermittent (recurrent
abdominal pain or RAP) or continuous. Although the exact cause is not known,
nerve signals or chemicals secreted by the gut or brain, may cause the gut to
be more sensitive to triggers that normally do not cause significant pain (such
as stretching or gas bloating). Because of this change in bowel function, this
type of abdominal pain is often referred to as “functional abdominal pain.”
Parents and children need to be reassured that functional abdominal
pain is not life threatening. However, functional abdominal pain may have
negative effects on the child’s physical and psychological state. The pain may
interfere with school attendance, participation in sports and other
extra-curricular activities. Infrequently, it may affect appetite and sleep.
The changes in the daily routine may affect the child’s mood and emotions, and
in turn cause depression and anxiety. In some cases, children previously
suffering from anxiety, depression and other psychiatric disorders may show an
exaggerated pain response. Sometimes, the parent and the child may not be
consciously aware of any stress or emotional disturbances.
Most young children will
point to the umbilicus (belly button) when asked to describe the location of
abdominal pain. However, pain centered around the belly button could be due to a number of causes
that should be considered w hen evaluating a child
with chronic abdominal pain. Some of those causes are not very serious while
other causes require close and long term care. Possible causes that should be
considered based on the history, physical examination and testing, are acid
reflux, constipation, lactose intolerance, parasitic infections of the small
and large intestines, infections of the stomach with a germ called Helicobacter
pylori (that is associated with ulcers in the first portion of the small bowel),
inflammatory bowel diseases (IBD) such as Crohn’s
disease and ulcerous colitis, celiac disease which is a sensitivity to cereal
grains, food allergies, inflammation of the liver (hepatitis), gall bladder
problems, an inflamed pancreas, an
intestinal obstruction (blockage), appendicitis, and many more rare disorders.
It must be emphasized that typically, none of these more severe problems cause
abdominal pain in most children with chronic or recurrent bellyaches. Instead,
the pain is usually “functional”.
Diagnosis
The diagnosis of
functional abdominal pain is often based on the report of symptoms and normal
physical examination. It is also quite possible that the doctor may obtain some
tests. The reason for these tests is to look for signs of any serious disease.
These screening tests may initially include blood and stool tests. The results
of screening tests often guide the doctor in deciding whether further tests are
needed or whether a trial of diet changes, stress management or medication may
be started. Testing should be limited if the history is typical for functional
abdominal pain and the child’s physical examination is normal. In that case, many doctors prefer to treat
without testing in order to avoid the discomfort of testing or the slight risk
associated with testing. Of course, if
the history, the physical examination, or the results of screening tests are
abnormal, further testing may be required.
This further testing may include a test to confirm lactose intolerance,
ultrasound of the abdomen, a CT of the abdomen, and upper GI series (radiology
test), and possibly an endoscopy (scope). The scope allows the doctor to use a
special camera on the scope to look at the inner lining of the food pipe,
stomach, first and last portion of the small intestine and the large intestine.
At the time of the scope, biopsies (small pinches of the lining) are also
obtained and examined under the microscope for signs of certain infections and
disorders like IBD and celiac disease. Normal test results in a child without
alarm signs or red flags strongly suggest RAP or one of the other types of
functional abdominal pain, such as irritable bowel syndrome or functional
dyspepsia.
Treatment
If a specific cause for
abdominal pain is discovered during the evaluation, the physician will discuss
specific management of conditions like constipation, lactose intolerance,
infections, IBD, celiac disease, and food allergies. If no specific cause is
found and functional abdominal pain is suspected, the child needs to be
reassured that his or her abdominal pain is accepted as a real disorder and not
something that is “just in the head”. The goal of managing functional abdominal
pain is to provide a satisfactory quality of life through support, education,
medicines and better coping skills.
Reassurance about the good outcome of functional abdominal pain and the
positive aspects of the child’s health are crucial. Addressing the parents’ and
child’s concerns and fears and identifying emotional or psychological stressors
are also important. As noted before, some tests may be needed during the
evaluation of functional abdominal pain, but it is also important for parents and
children to know that doing too many unnecessary tests may be frustrating to
the family and child. If functional abdominal pain is strongly suspected as the
likely diagnosis, testing should be limited to the most useful, simple and
relatively non-invasive tests.
The child may benefit from
certain dietary changes depending on his/her history. These are recommended on
a case-by-case basis. The physician may advise avoidance of greasy and spicy
foods, caffeine, juices, and carbonated drinks. Eliminating lactose (a natural
sugar in milk and other dairy products) from the diet may benefit those who
suffer from lactose intolerance in addition to functional abdominal pain. Some
children with abdominal pain who also experience “gas” may improve by eating
food slowly and by avoiding carbonated drinks, and gas forming foods such as
cabbage, or beans. In addition, fruit drinks, sugar-free chewing gum, and sugar
free candy sweetened with an alcohol called sorbitol should be avoided. Sorbitol, which tastes sweet, cannot be
properly digested, and when taken in large amounts, it can cause cramping,
bloating, and even diarrhea.
Some children may be candidates
for medications, if functional abdominal pain is significantly limiting the daily
routine. These medications include anti-spasmodic medicines for those with crampy pain in relation to bowel movements, laxatives for
those with constipation, and acid-suppressing medicines for those with pain and
dyspepsia. If the child does not respond to any of these treatments, he or she
may benefit from low doses of medicines called tricyclic antidepressants (used
at much higher doses to treat depression). At low doses, these medicines can be
excellent pain relievers for some children. A fearful, anxious, or depressed
child however should be fully assessed by a psychiatrist or psychologist. Some
psychological treatments that help children cope with functional abdominal pain
and other stressors , include behavioral
therapy, relaxation exercises and hypnosis. It is very important that the
physician, parents, and school encourage the child resume a normal
routine.
Prognosis
Fortunately, the
diagnosis of functional abdominal pain has a good outcome overall, with almost
half of these children getting better on their own or with treatment within a
few weeks to months. A supportive and understanding environment at home and
school is important to keep the child physically and mentally healthy.
Functional constipation
Constipation has been
defined as “a delay or difficulty in defecation, present for two or more weeks,
sufficient to cause significant distress to the patient. This condition is
responsible for an estimated 3 to 5 percent of physician visits by children.
Constipation often causes more distress to parents and other caregivers than to
the affected child. Many caregivers worry that a child’s constipation is the
sign of a serious medical problem.
Constipation is responsible for
up to 5% of pediatric office visits. It is defined as
delay or difficulty in the passing of hard, sometimes large stools for ≥
2 wk.
The
frequency of normal bowel movements varies for infants. In the first year, the
average number of bowel movements ranges from 2 to 4/day. This number also
varies depending on whether infants are breastfed or formula-fed (breastfed
infants have more frequent bowel movements). In general, signs of effort (eg, straining) do not signify constipation; infants only
gradually develop the muscles to assist a bowel movement. After age 1 yr, children average 1 bowel movement/day.
Etiology
Constipation in children is divided
into 2 main types:
·
Organic (5%)
·
Functional (95%)
Organic: Organic causes involve
specific structural, neurologic, toxic/metabolic, or intestinal disorders. They
are rare but important to recognize. The most common cause is Hirschsprung's disease.
Other organic causes that may
manifest in the neonatal period or later include:
Ø Anorectal
malformations
Ø Cystic
fibrosis
Ø Metabolic
disorders (eg, hypothyroidism, hypercalcemia,
hyperkalemia)
Ø Spinal
cord abnormalities
Functional: Functional
constipation is difficulty passing stools for reasons other than organic
causes.
In infants, the use of formula
can lead to small, hard stools.
Causes of constipation in babies
§ Babies
who are bottle fed often suffer from constipation due to lack of water in their
diet.
§ Even
breastfed babies may suffer from constipation if their mothers follow improper
diet.
§ When
a baby is introduced to solids, frequent change in their diet may cause
constipation.
§ If
the baby takes more of fat or protein but less of fiber
then they may suffer from constipation.
§ If
a child has infant rickets then also he/she may have constipation.
§ If
a child suffers from anemia which is induced by iron
deficiency then there are chances of constipation.
§ Hypothyroidism
causes constipation.
§ Sometimes
allergy to certain food like cow’s milk, eggs or fish may cause inflammation
which in turn causes constipation.
§ Sometimes
toddlers avoid toilet. They may avoid their toilet trips when her environment
changes like when she joins preschool or when she is too busy with playing.
Often presence of anal fissures may make defecation painful for which she may
avoid defecating.
§ Long
term use of medicines like antibiotics and anticonvulsants often result in
constipation.
Baby constipation effects on a baby’s body
Þ Constipation
often makes babies cranky, lethargic and she may lose appetite also.
Þ Malabsorption
of essential vitamins and minerals in the body create imbalance which may
finally lead to iron deficiency.
Þ Constipation
in babies may cause inflammation of the intestine which results in abdominal
pain.
Þ Chronic
constipation often leads to certain medical complications. Blood circulation in
the intestine of the baby may be hampered and inflammation in colon can also
occur.
Þ Cracks
may develop in the babies’ rectum due to constipation. Appearance of blood in
stool may follow which requires immediate medical attention.
In older children, diets
low in fiber and high in dairy lead to hard stools
that are uncomfortable to pass and can cause anal fissures. Children sometimes
put off having bowel movements because they have discomfort caused by fissures
or because they do not want to interrupt play. To avoid having a bowel
movement, children may tighten the external sphincter muscles, pushing the
stool higher in the rectal vault.
If this behavior
is repeated, the rectum stretches to accommodate the retained stool. The urge
to defecate is then decreased, and the stool becomes harder, leading to a
vicious circle of painful defecation and worsened constipation. Occasionally,
soft stool passes around the impacted stool and leads to stool incontinence.
Stress, toilet training, desire
for control, and sexual abuse are also some of the functional causes of stool
retention and subsequent constipation.
Evaluation
Evaluation should focus on
differentiating functional constipation from constipation with an organic
cause.
History
History of present illness in
neonates should determine whether meconium has been passed at all and, if so,
when. For older infants and children, history should note onset and duration of
constipation, frequency and consistency of stools, and timing of
symptoms—whether they began after a specific event, such as introduction of
certain foods or a stressor that could lead to stool retention (eg, introduction of toilet training). Important associated
symptoms include soiling (stool incontinence), discomfort during defecation,
and blood on or in the stool. The composition of the diet, especially the
amount of fluids and fiber, should be noted.
Symptoms of constipation
·
painful bowel movements
·
stomach pain/abdominal distention
·
rectal bleeding from tears (fissures)
·
poor appetite
·
irritability/crankiness
·
urine
problems (recurrent infections, bedwetting).
Review of systems should
ask about symptoms that suggest an organic cause, including new onset of poor
suck, hypotonia, and ingestion of honey before age 12
mo (infantile botulism); cold intolerance, dry skin,
fatigue, hypotonia, prolonged neonatal hyperbilirubinemia, urinary frequency, and excessive thirst
(endocrinopathies); change in gait, pain or weakness
in lower extremities, and urinary incontinence (spinal cord defects); night
sweats, fever, and weight loss and vomiting, abdominal pain, poor growth,
intermittent diarrhea, and constipation (intestinal
disorders).
Past medical history should ask about
known disorders that can cause constipation, including cystic fibrosis and
celiac sprue. Exposure to constipating drugs or lead
paint dust should be noted. Clinicians should ask about delayed passage of
meconium within the first 24 to 48 h of life, as well as previous episodes of
constipation and family history of constipation.
Physical examination
The physical examination begins
with general assessment of the child's level of comfort or distress and overall
appearance (including skin and hair condition). Height and weight should be
measured and plotted on growth charts.
Examination should focus on the
abdomen and anus and on the neurologic examination.
The abdomen is inspected for
distention, auscultated for bowel sounds, and palpated for masses and
tenderness. The anus is inspected for a fissure (taking care not to spread the
buttocks so forcefully as to cause one). A digital rectal examination is done
gently to check stool consistency and to obtain a sample for occult blood
testing. Rectal examination should note the tightness of the rectal opening and
presence or absence of stool in the rectal vault. Examination includes
placement of the anus and presence of any hair tuft or pit superior to the
sacrum.
Auscultation
for bowel sounds
In infants, neurologic examination
focuses on tone and muscle strength. In older children, the focus is on gait,
deep tendon reflexes, and signs of weakness in the lower extremities.
Interpretation of findings
A primary finding that
suggests an organic cause in neonates is constipation from birth; those who
have had a normal bowel movement are unlikely to have a significant structural
disorder.
In older children, clues to
an organic cause include constitutional symptoms (particularly weight loss,
fever, vomiting), poor growth (decreasing percentile on growth charts), an
overall ill appearance, and any focal abnormalities detected during
examination. A well-appearing child who has no other complaints besides
constipation, who is not on any constipating drugs, and who has a normal
examination likely has a functional disorder.
A distended rectum
filled with stool or the presence of an anal fissure is consistent with
functional constipation in an otherwise normal child. Constipation that began
after starting a constipating drug or that coincides with a dietary change can
be attributed to that drug or food. Foods that are known to be constipating
include dairy (eg, milk, cheese, yogurt)
and starches and processed foods that do not contain fiber.
However, if constipation complaints begin after ingestion of wheat, celiac sprue should be considered. History of a new stress (eg, a new sibling) or other potential causes of stool
retention behavior, with normal physical findings,
support a functional etiology.
The following findings are of particular
concern:
ü Delayed
passage of meconium (> 24 to 48 h after birth)
ü Hypotonia and poor
suck (suggesting infant botulism)
ü Abnormal
gait and deep tendon reflexes (suggesting spinal cord involvement)
Testing
For patients whose
histories are consistent with functional constipation, no tests are needed unless
there is no response to conventional treatment. An abdominal x-ray should be
done if patients have been unresponsive to treatment or an organic cause is
suspected. Tests for organic causes should be done based on the history and
physical examination.
Barium
enema, rectal manometry, and biopsy (Hirschsprung's disease)
Plain
x-rays of lumbosacral spine; MRI considered (tethered spinal cord or tumor)
Thyroid-stimulating
hormone and thyroxine (hypothyroidism)
Blood
lead level (lead poisoning)
Stool
for botulinum toxin (infant botulism)
Sweat
test and genetic testing (cystic fibrosis)
Ca
and electrolytes (metabolic derangement)
IgA
and IgG anti-gliadin
antibodies, IgA anti-endomysium antibodies, IgA
anti-tissue glutaminase (celiac disease)
Treatment
Specific organic causes
should be treated. Functional constipation is ideally initially treated with
dietary changes and behavior modification.
Diets high in protein and fiber give the body the essential fuels needed to build
muscle, increase energy and exercise to lose fat, rather than muscle. Purify
the digestive tract by eating large amounts of roughage like spinach, romaine
lettuce, fruit and whole grains and oats. Protein-rich diets help keep
everybody full, while fiber-rich.
Dietary changes include
adding prune juice to formula for infants, increasing fruits and vegetables for
older infants and children, increasing water intake, and decreasing the amount
of constipating foods (eg, milk, cheese).
Behavior
modification for older children involves encouraging regular stool passage
after meals if they are toilet trained and providing a reinforcement chart and
encouragement to them. For children who are in the process of toilet training,
it is sometimes worthwhile to give them a break from training until the
constipation concern has passed.
Unresponsive constipation
is treated by disimpacting the bowel and maintaining
a regular diet and stool routine. Disimpaction can
occur through oral or rectal agents. Oral agents require consumption of large
volumes of liquid. Rectal agents can feel invasive and can be difficult to
give. Both methods can be done by parents under medical supervision; however, disimpaction sometimes requires hospitalization if
outpatient management is unsuccessful. Usually, infants do not require extreme
measures, but if intervention is required, a glycerin
suppository is typically adequate.
For
maintenance of healthy bowels, some children may require OTC dietary fiber supplements. These supplements require consuming 32
to
Organic bowel disease
The inflammatory bowel disease (IBD)
include Crohn's disease and ulcerous colitis.
Crohn's
disease (also known as granulomatous, and colitis) is an inflammatory disease
of the intestines that may affect any part of the gastrointestinal tract from
mouth to anus, causing a wide variety of symptoms. It primarily causes
abdominal pain, diarrhea (which may be bloody),
vomiting, or weight loss, but may also cause complications outside of the
gastrointestinal tract such as skin rashes, arthritis, inflammation of the eye,
tiredness, and lack of concentration.
Crohn's
disease is thought to be an autoimmune disease, in which the body's immune
system attacks the gastrointestinal tract, causing inflammation; it is
classified as a type of inflammatory bowel disease. There has been evidence of
a genetic link to
Crohn's disease, putting individuals with
siblings afflicted with the disease at higher risk. It is understood to have a
large environmental component as evidenced by the higher number of cases in
western industrialized nations.
Males and females are equally
affected. Smokers are three times more likely to develop Crohn's
disease. Crohn's
disease affects between 400,000 and 600,000 people in North America. Prevalence
estimates for Northern Europe have ranged from 27–48 per 100,000. Crohn's disease tends to present initially in the teens and
twenties, with another peak incidence in the fifties to seventies, although the
disease can occur at any age.
There is no known pharmaceutical or
surgical cure for Crohn's disease.Treatment
options are restricted to controlling symptoms, maintaining remission and
preventing relapse.
The disease was named for
American gastroenterologist Burrill Bernard Crohn, who in 1932, along with two colleagues, described a
series of patients with inflammation of the terminal ileum, the area most
commonly affected by the illness.
Classification
Distribution of
gastrointestinal Crohn's disease. Based on data from
American Gastroenterological Association.
Crohn's
disease is one type of inflammatory bowel disease (IBD). It affects the
gastrointestinal tract and can be categorized by the area of the
gastrointestinal tract which it affects. Ileocolic Crohn's disease, which affects both the ileum (the last
part of the small intestine that connects to the large intestine) and the large
intestine, accounts for fifty percent of cases. Crohn's
ileitis, affecting the ileum only, accounts for thirty percent of cases, and Crohn's colitis, affecting the large intestine, accounts
for the remaining twenty percent of cases and may be particularly difficult to
distinguish from ulcerous colitis. Gastroduodenal Crohn's disease causes inflammation in the stomach and
first part of the small intestine, called the duodenum. Jejunoileitis
causes spotty patches of inflammation in the top half of the small intestine,
called the jejunum. The disease can attack any part of the digestive tract,
from mouth to anus. However, individuals affected by the disease fall these
three classifications rarely, being affected in other parts of the
gastrointestinal tract such as the stomach and esophagus.
Crohn's
disease may also be categorized by the behavior of
disease as it progresses. This was formalized in the Vienna classification of Crohn's disease.
There are three categories of
disease presentation in Crohn's disease: stricturing, penetrating, and inflammatory. Stricturing disease causes narrowing of the bowel that may
lead to bowel obstruction or changes in the caliber
of the feces. Penetrating disease creates abnormal
passageways (fistulae) between the bowel and other structures such as the skin.
Inflammatory disease (or non-stricturing,
non-penetrating disease) causes inflammation without causing strictures or
fistulae.
Crohn's Disease - Affected Areas
Causes
Although the exact cause of Crohn's disease is still unknown, a combination of
environmental factors and genetic predisposition seems to cause the disease.
The genetic risk factors have now more or less been comprehensively elucidated,
making Crohn's disease the first genetically complex
disease of which the genetic background has been resolved. The relative risks
of contracting the disease when one has a mutation in one of the risk genes,
however, are actually very low (approximately 1:200). Broadly speaking, the
genetic data indicate that innate immune systems in patients with Crohn's disease malfunction, and direct assessment of
patient immunity confirms this notion. This had led to the notion that Crohn's disease should be viewed as innate immune
deficiency, chronic inflammation being caused by adaptive immunity trying to
compensate for the reduced function of the innate immune system.
Genetics
Schematic of NOD2 CARD15
gene, which is associated with certain disease patterns in Crohn's
disease.
Some research has indicated
that Crohn's disease may have a genetic link. The
disease runs in families and those with a sibling with the disease are 30 times
more likely to develop it than the general population.
Mutations in the CARD15 gene
(also known as the NOD2 gene) are associated with Crohn's
disease and with susceptibility to certain phenotypes of disease location and
activity. In earlier studies, only two genes were linked to Crohn's,
but scientists now believe there are over thirty genes that show genetics play
a role in the disease, either directly through causation or indirectly as with
a mediator variable. Anomalies in the XBP1 gene have recently been identified
as a factor, pointing towards a role for the unfolded protein response pathway
of the endoplasmatic reticulum in inflammatory bowel
diseases.
Environmental factors
Diet is believed to
be linked to its higher prevalence in industrialized parts of the world. A positive
correlation has been found between the incidence of the disease and an
increased intake of animal protein, milk protein and an increased ratio of n-6
to n-3 polyunsaturated fatty acids. Negative correlation of the disease
incidence was found to the increased consumption of vegetable protein, and no
correlation to fish protein. Smoking has been shown to increase the risk of the
return of active disease, or "flares".
Immune system
Abnormalities in the
immune system have often been invoked as being causes of Crohn's
disease. Crohn's disease is thought to be an
autoimmune disease, with inflammation stimulated by an over-active Th1 cytokine
response. However, more recent evidence has shown that Th17 is of greater
importance in the disease.
The most recent gene
to be implicated in Crohn's disease is ATG16L1, which
may induce autophagy and hinder the body's ability to attack invasive bacteria.
Contrary to the
prevailing view that Crohn's disease is a primary T
cell autoimmune disorder, there is an increasing body of evidence in favor of the hypothesis that Crohn's
disease results from an impaired innate immunity. The immunodeficiency, which
has been shown to be due to (at least in part) impaired cytokine secretion by
macrophages, is thought to lead to a sustained microbial-induced inflammatory
response, particularly in the colon where the bacterial load is especially
high.
Microbes
A variety of pathogenic bacteria
were initially suspected of being causative agents of Crohn's
disease. However, most health care professionals now believe that a variety of
microorganisms are taking advantage of their host's weakened mucosal layer and
inability to clear bacteria from the intestinal walls, both symptoms of the
disease. Some studies have suggested that Mycobacterium avium
subspecies paratuberculosis (MAP) plays a role in Crohn's disease, in part because it causes a very similar
disease, Johne's disease, in cattle. The mannose
bearing antigens (mannins) from yeast may also elicit
an antibody response. Other studies have linked specific strains of enteroadherent E. coli to the disease. Still, this
relationship between specific types of bacteria and Crohn's
disease remains unclear.
Some
studies have suggested that some symptoms of Crohn's
disease, ulcerous colitis and irritable bowel syndrome have the same underlying
cause. Biopsy samples taken from the colons of all three patient groups were
found to produce elevated levels of a serine protease. Experimental
introduction of the serine protease into mice has been found to produce
widespread pain associated with irritable bowel syndrome as well as colitis,
which is associated with all three diseases.
A study in 2003 put forth the
"cold-chain" hypothesis, that psychrotrophic
bacteria such as Yersinia spp and Listeria spp contribute to the disease. A statistical correlation
was found between the advent of the use of refrigeration in the United States
and various parts of Europe and the rise of the disease. Later studies have
provided support for this hypothesis.
Studies done at the University
of Liverpool have offered ideas that would explain the apparent connection
between Crohn's disease, Mycobacterium, other
pathogenic bacteria, and genetic markers. In many individuals genetic factors
predispose individuals to Mycobacterium avium subsp. paratuberculosis infection. These bacteria then produce mannins which protect both itself and various bacteria from
phagocytosis, which causes a variety of secondary infections. Other
mycobacterial diseases, such as leprosy and Tuberculosis could be considered
similar in that they have strong genetic components, but are not genetic per
se.
Clinics
Abdominal
pain may be the initial symptom of Crohn's disease.
It is often accompanied by diarrhea, especially in
those who have had surgery. The diarrhea may or may
not be bloody. People who have had surgery or multiple surgeries often end up
with short bowel syndrome of the gastrointestinal tract. The nature of the diarrhea in Crohn's disease
depends on the part of the small intestine or colon that is involved. Ileitis
typically results in large-volume watery feces.
Colitis may result in a smaller volume of feces of
higher frequency. Fecal consistency may range from
solid to watery. In severe cases, an individual may have more than 20 bowel
movements per day and may need to awaken at night to defecate. Visible bleeding
in the feces is less common in Crohn's
disease than in ulcerous colitis, but may be seen in the setting of Crohn's colitis. Bloody bowel movements are typically
intermittent, and may be bright or dark red in colour. In the setting of severe
Crohn's colitis, bleeding may be copious. Flatulence
and bloating may also add to the intestinal discomfort.
Symptoms caused by intestinal stenosis are also common in Crohn's disease. Abdominal pain is often most severe in
areas of the bowel with stenosis. In the setting of severe stenosis, vomiting
and nausea may indicate the beginnings of small bowel obstruction. Although the
association is greater in the context of ulcerous colitis, Crohn's
disease may also be associated with primary sclerosing
cholangitis, a type of inflammation of the bile ducts.
Perianal discomfort may also be prominent in Crohn's
disease. Itchiness or pain around the anus may be suggestive of inflammation, fistulization or abscess around the anal area or anal
fissure. Perianal skin tags are also common in Crohn's
disease. Fecal incontinence may accompany peri-anal Crohn's disease. At the
opposite end of the gastrointestinal tract, the mouth may be affected by
non-healing sores (aphthous ulcers). Rarely, the esophagus, and stomach may be involved in Crohn's disease. These can cause symptoms including
difficulty swallowing (dysphagia), upper abdominal pain, and vomiting.
Pyoderma gangrenosum on Erythema nodosum on the back
a leg of a person with of a
person with Crohn's
Crohn's
disease.
disease.
Diagnosis
Endoscopic image of Crohn's
colitis showing deep ulceration
CT
scan showing Crohn's disease in the fundus of the
stomach
Crohn's
disease can mimic ulcerous colitis on endoscopy. This endoscopic image is of Crohn's colitis showing diffuse loss of mucosal
architecture, friability of mucosa in sigmoid colon and exudate on wall, all of
which can be found with ulcerous colitis.
The diagnosis of Crohn's
disease can sometimes be challenging, and a number of tests are often required
to assist the physician in making the diagnosis. Even with a full battery of
tests it may not be possible to diagnose Crohn's with
complete certainty; a colonoscopy is approximately 70% effective in diagnosing
the disease with further tests being less effective. Disease in the small bowel
is particularly difficult to diagnose as a traditional colonoscopy only allows
access to the colon and lower portions of the small intestines; introduction of
the capsule endoscopy aids in endoscopic diagnosis.
Endoscopy
A colonoscopy is the best
test for making the diagnosis of Crohn's disease as
it allows direct visualization of the colon and the terminal ileum, identifying
the pattern of disease involvement. Occasionally, the colonoscope
can travel past the terminal ileum but it varies from patient to patient.
During the procedure, the gastroenterologist can also perform a biopsy, taking
small samples of tissue for laboratory analysis which may help confirm a
diagnosis. As 30% of Crohn's disease involves only
the ileum, cannulation of the terminal ileum is
required in making the diagnosis. Finding a patchy distribution of disease,
with involvement of the colon or ileum but not the rectum, is suggestive of Crohn's disease, as are other endoscopic stigmata. The
utility of capsule endoscopy for this, however, is still uncertain.
Radiologic tests
A small bowel
follow-through may suggest the diagnosis of Crohn's
disease and is useful when the disease involves only the small intestine.
Because colonoscopy and gastroscopy allow direct visualization of only the
terminal ileum and beginning of the duodenum, they cannot be used to evaluate
the remainder of the small intestine. As a result, a barium follow-through
x-ray, wherein barium sulfate suspension is ingested
and fluoroscopic images of the bowel are taken over time, is useful for looking
for inflammation and narrowing of the small bowel. Barium enemas, in which
barium is inserted into the rectum and fluoroscopy used to image the bowel, are
rarely used in the work-up of Crohn's disease due to
the advent of colonoscopy. They remain useful for identifying anatomical
abnormalities when strictures of the colon are too small for a colonoscope to pass through, or in the detection of colonic
fistulae.
CT
and MRI scans are useful for evaluating the small bowel with enteroclysis protocols. They are additionally useful for
looking for intra-abdominal complications of Crohn's
disease such as abscesses, small bowel obstruction, or fistulae. Magnetic
resonance imaging (MRI) is another option for imaging the small bowel as well
as looking for complications, though it is more expensive and less readily
available.
Blood tests
A complete blood
count may reveal anemia, which may be caused either
by blood loss or vitamin B12 deficiency. The latter may be seen with
ileitis because vitamin B12 is absorbed in the ileum. Erythrocyte sedimentation
rate, or ESR, and C-reactive protein measurements can also be useful to gauge
the degree of inflammation. It is also true in patient with ilectomy
done in response to the complication. Another cause of anaemia is anaemia of
chronic disease, characterized by its microcytic and hypochromic anaemia. There
can be various reasons for anaemia, including medication used in treatment of
inflammatory bowel disease like azathioprine which can lead to cytopenia and sulfasalazine which can also result in folate
malabsorption, etc. Testing for anti-Saccharomyces cerevisiae
antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (ANCA) has been
evaluated to identify inflammatory diseases of the intestine and to
differentiate Crohn's disease from ulcerous colitis.
Furthermore, increasing amounts and levels of serological antibodies such as
ASCA, anti-laminaribioside aid in the prognosis of Crohn's disease.
Comparison with ulcerous colitis
The most common
disease that mimics the symptoms of Crohn's disease
is ulcerous colitis, as both are inflammatory bowel diseases that can affect
the colon with similar symptoms. It is important to differentiate these
diseases, since the course of the diseases and treatments may be different. In
some cases, however, it may not be possible to tell the difference, in which
case the disease is classified as indeterminate colitis.
Treatment
Currently there is no cure for Crohn's disease and remission may not be possible or
prolonged if achieved. In cases where remission is possible, relapse can be
prevented and symptoms controlled with medication, lifestyle changes and in
some cases, surgery. Adequately controlled, Crohn's
disease may not significantly restrict daily living. Treatment for Crohn's disease is only possible when symptoms are active
and involve first treating the acute problem, then maintaining remission.
Medication
Acute treatment uses medications to
treat any infection (normally antibiotics) and to reduce inflammation (normally
aminosalicylate anti-inflammatory drugs and
corticosteroids). When symptoms are in remission, treatment enters maintenance
with a goal of avoiding the recurrence of symptoms. Prolonged use of
corticosteroids has significant side-effects; as a result they are generally
not used for long-term treatment. Alternatives include aminosalicylates
alone, though only a minority are able to maintain the treatment, and many
require immunosuppressive drugs. It has been also suggested that antibiotics
change the enteric flora and their continuous use may pose the risk of
overgrowth with pathogens such as Clostridium difficile.
Medications used to treat
the symptoms of Crohn's disease include
5-aminosalicylic acid (5-ASA) formulations, prednisone, immunomodulators such as azathioprine, mercaptopurine, methotrexate, infliximab, adalimumab, certolizumab and natalizumab. Hydrocortisone should be used in severe attacks
of Crohn's disease. Since
late 1990s, biological medications are available.
Lifestyle changes
Certain lifestyle changes can reduce
symptoms, including dietary adjustments, proper hydration and smoking
cessation. Smoking may increase Crohn's disease,
stopping is recommended. Eating small meals frequently instead of big meals may
also help with a low appetite. To manage symptoms have a balanced diet with
proper portion control. Fatigue can be helped with regular exercise, a healthy
diet, and enough sleep. A food diary may help with identifying foods that
trigger symptoms. Some patients should follow a low dietary fiber
diet to control symptoms especially if fibrous foods cause symptoms.
Surgery
Crohn's
cannot be cured by surgery, though it is used when partial or a full blockage
of the intestine occurs. Surgery may also be required for complications such as
obstructions, fistulas and/or abscesses, or if the disease does not respond to
drugs. After the first surgery, Crohn's usually shows
up at the site of the resection though it can appear in other locations. After
a resection, scar tissue builds up which can cause strictures. A stricture is
when the intestines become too small to allow excrement to pass through easily
which can lead to a blockage. After the first resection, another resection may
be necessary within five years. For patients with an obstruction due to a
stricture, two options for treatment are strictureplasty
and resection of that portion of bowel. There is no statistical significance
between strictureplasty alone versus strictureplasty and resection in cases of duodenal
involvement. In these cases, re-operation rates were 31% and 27%, respectively,
indicating that strictureplasty is a safe and
effective treatment for selected patients with duodenal involvement.
Short bowel syndrome (SBS, also
short gut syndrome or simply short gut) can be caused by the surgical removal
of the small intestines. It usually develops if a person has had half or more
of their small intestines removed. Diarrhea is the
main symptom of short bowel syndrome though other symptoms may include
cramping, bloating and heartburn. Short bowel syndrome is treated with changes
in diet, intravenous feeding, vitamin and mineral supplements and treatment
with medications. Another complication following surgery for Crohn's disease where the terminal ileum has been removed
is the development of excessive watery diarrhea. This
is due to an inability to reabsorb bile acids after resection of the terminal
ileum.
In some cases of SBS, intestinal
transplant surgery may be considered; though the number of transplant centres
offering this procedure is quite small and it comes with a high risk due to the
chance of infection and rejection of the transplanted intestine.
Prospective treatments
Researchers at University
College London have questioned the wisdom of suppressing the immune system in Crohn's, as the problem may be an under-active rather than
an over-active immune system: their study found that Crohn's
patients showed an abnormally low response to an introduced infection, marked
by a poor flow of blood to the wound, and the response improved when the
patients were given sildenafil citrate.
Recent studies using helminthic
therapy or hookworms to treat Crohn's Disease and
other (non-viral) auto-immune diseases seem to yield promising results.
Complementary and alternative medicine
More than half of Crohn's disease sufferers have tried complementary or
alternative therapy. These include diets, probiotics, fish oil and other herbal
and nutritional supplements. The benefit of these medications is uncertain.
Acupuncture
is used to treat inflammatory bowel disease in China, and is being used more
frequently in Western society. However, there is no evidence that acupuncture
has benefits beyond the placebo effect. Methotrexate is a folate
anti-metabolite drug which is also used for chemotherapy. It is useful in
maintenance of remission for those no longer taking corticosteroids.
Metronidazole and ciprofloxacin are
antibiotics which are used to treat Crohn's that have
colonic or perianal involvement, although, in the United States, this use has
not been approved by the Food and Drug Administration. They are also used for
treatment of complications, including abscesses and other infections
accompanying Crohn's disease.
Ulcerous colitis
Ulcerous colitis is the illness called inflammatory bowel disease
(IBD).
In ulcerous colitis, the
inner lining of the large intestine or bowel (colon) and the rectum become
inflamed (irritated or raw and swollen). Ulcerous colitis can affect the entire
colon, but it is usually in the rectum and the lower part of the colon.
Inflammation from ulcerous colitis can make the colon empty often, which causes
diarrhea. Ulcers form, causing bleeding.
Causes
There is no known cause
for ulcerous colitis, but there are many theories about its cause. One theory
is that the body's immune system (that fights off infection) reacts to a virus
or bacteria. This reaction cannot stop and causes chronic (ongoing)
inflammation in the intestine.
It has been proven that
patients with ulcerous colitis have abnormalities (problems) in the immune
system. It is not known if these abnormalities are a cause of the disease or a
result of the disease. There is little evidence that ulcerous colitis is caused
by emotional distress or allergy to certain foods.
The most common symptoms
of ulcerous colitis are stomach pain and bloody diarrhea
(loose bowel movements).
Other symptoms that can
occur include:
Ø Rectal
bleeding (blood in bowel movements)
Ø Fatigue
(tiredness)
Ø Loss
of appetite
Ø Weight
loss
Ø Skin
problems
Ø Joint
pain
Ø Stunted
growth
Diagnostics
Ulcerous colitis is diagnosed
by a complete medical history and physical examination along with medical
tests. The main goal of the tests is to make sure that the disease is ulcerous colitis
and not some other kind of disease that causes diarrhea.
Testing for ulcerous colitis includes the
following:
Blood
tests check for anemia (low red blood cell count),
which can mean bleeding in the colon or rectum. They can also show if there is
an increased number of white blood cells, which might mean that there is
inflammation somewhere in the body.
Stool
cultures tell if there is an infection by a parasite, virus or bacteria. Stool
can also be tested for occult (hidden) blood that is not seen on the stool.
Sigmoidoscopy is a test
using a flexible tube with a light and camera lens at the end (sigmoidoscope) that is put into the rectum and lower colon
(sigmoid colon). It lets the doctor see inflammation in the lining of the
rectum and lower colon.
Colonoscopy
is a test that uses a long, flexible tube with a light and camera lens at the
end (colonoscope). This allows the doctor to examine
the lining of the entire colon.
Biopsy
is a tissue sample that is taken for examination and testing in a laboratory.
In ulcerous colitis, a biopsy (a small piece of tissue from the lining of the
large bowel) is usually done during a sigmoidoscopy
or colonoscopy.
Barium
enema / X-ray is a procedure that examines the large intestine for
abnormalities. A chalky fluid called barium is put
into the rectum as an enema. The barium coats the inside of the colon so that
it will show up on an X-ray film (picture). An X-ray of the colon shows ulcers
(sores) and other problems.
Treatment
Treatment for ulcerous colitis
is different from one child to another. What helps one patient may not help
another. Treatment for ulcerous colitis depends upon many things:
·
Health of the child
·
How much of the colon is inflamed
·
Ability of the child to take certain
medicines or undergo certain procedures
The goal of treatment is to:
Ø Put
the disease into remission (making the disease inactive)
Ø Help
keep the disease in remiss
Ø Improve
the quality of life
Some patients go into
remission (the symptoms of ulcerous colitis go away). However, it is not
uncommon for the symptoms to come back (a "flare").
Specific Carbohydrate Diet
"If there is no clear
history of lactose (milk sugar) intolerance, eliminating dairy products from
the diet is seldom suggested," according to the Crohn's
and Colitis Foundation of America (CCFA), which fears the move might cause
calcium deficiency in kids. However, parents looking for an alternative
nutritional therapy can cut out lactose while continuing to feed their children
healthy sources of calcium. The Specific Carbohydrate Diet (SCD) was created
for people with IBD and is based on the theory that if a food is known to cause
digestive issues in some people, then avoiding it will help the digestive
system heal; because of that, lactose is eliminated, but yogurt that has been
fermented for 24 hours to remove lactose, and aged cheeses that contain very
little, are allowed. The SCD, developed by Sidney Haas, MD, and biochemist
Elaine Gottschall, MD, also requires that starches,
sugars and all other complex carbohydrates (disaccharides and polysaccharides)
be avoided. This includes grains, breads, rice, corn, potatoes and pasta. But monosaccharides, like honey, fruit and many vegetables,
which have a single-molecule structure and are easily digestedare
fine, although it should be noted that babies under 12 months old should not
eat honey. Also encouraged on the diet are pure proteins like eggs, nuts, meats
that haven't been processed or had fillers added and legumes that have been
soaked before cooking.
Dietary Supplements
Fish oil, rich in omega-3 essential
fatty acids, may bring relief to kids with colitis by reducing inflammation,
according to the information website ulcerative-colitis.org. The Mayo Clinic
agrees that fish oil is an anti-inflammatory, and points out that, while never
concretely proven, "one study that included large doses of fish oil 15 or
more capsules a day suggested a possible benefit." It also mentions a
small trial that showed that taking aloe vera gel
daily may help, and acknowledge that probiotics might help combat IBD by adding
beneficial bacteria to the gut.
Guidelines for the managements of
ulcerous colitis are diagnosed by clinical evaluation, colonoscopy, barium
enema, flexible sigmoidoscopy, laboratory tests and
stool studies. Treatment of this illness can require numerous adjustments of
therapy, depending on the situation and the individual patient. A close working
relationship with a gastroenterologist and/or surgeon is essential.
Medications
Three different types of
medicines may be used to help control the symptoms of ulcerous colitis. Each
helps decrease the inflammation in the lining of the colon.
Aminosalicylates (5-ASA
drugs) alter the body's ability to create and maintain inflammation. These
drugs are used to treat mild cases. They may be taken by mouth or given as an
enema or suppository. Examples include Asacol", Pentasa", Colazal", Dipentum" and azulfidine.
Corticosteroids
(such as prednisone) also affect the body's ability to create and maintain
inflammation. These medicines are given by mouth or by vein (intravenous) to
quiet down medium to severe disease symptoms, but they are not recommended for
long-term use because of their side effects. Steroids may also be given as an
enema or suppository for inflammation in the last part of the colon.
Immunomodulatory medicines
are used in patients when aminosalicylates and cortiosteroids do not work or when patients cannot get off
the steroids without their symptoms coming back. These drugs quiet down the
immune system but they can take as long as three months to work. Some examples
are Imuran (azathioprine) and purinethol (6-MP).
Surgery
Most patients with ulcerous
colitis do not need surgery. When medicine does not work, about 20 to 30
percent of patients must have surgery. Ulcerous colitis is cured when the colon
is removed.
Two types of surgery are common:
ü Ileoanal anastomosis.
This operation removes the diseased part of the colon. The outer muscles of the
rectum are not removed. The ileum is attached inside the rectum, forming a
pouch to hold waste. This allows the patient to pass stool through the anus in
a normal manner. Bowel movements may be more frequent and watery than usual.
ü Proctocolectomy. This surgery
removes the entire colon and rectum. A small opening is then made in the front
of the abdominal wall and the tip of the ileum (end of the lower intestine) is
brought to the skin's surface (this procedure is called an ileostomy). The
opening of the ileostomy (called a stoma allows drainage of waste into a bag
(outside of the body).
The Procedure
Ø The
colon and rectum are removed.
Ø The
anus and surrounding muscles are left in place.
Ø Part
of the small intestine is reshaped to form a pouch within the body. The pouch
works like a rectum. It stores waste until a bowel movement occurs.
Ø A
temporary ileostomy may be needed as the intestine heals. This is a procedure
that lets waste pass into a pouch outside the body.
Patients can live normal
and active lives after surgery.
Risks and Complications
Bowel
surgery has certain risks and possible complications. They may include:
Infection
Injury
to nearby organs
An
anastomosis that leaks
Blood
clots
Risks
related to anesthesia
Differential diagnosis of Inflammatory
Bowel Disease
Symptoms |
Ulcerous Colitis |
Crohn's
Disease |
Diarrhea
|
Recurrent diarrhea is very
common, but onset may be very gradual and mild or it may not be present. Feces may also contain mucus. |
Recurrent diarrhea is
fairly common. |
Rectal Bleeding |
Blood is almost always present in stools. It may be
readily visible or visible only using a microscope (called occult blood). |
Bleeding not as common as in UC, but can occur. |
Constipation |
Constipation can be a symptom of UC, but not as
common as diarrhea. Can occur during flare-ups. May
occur when the inflamed rectum triggers a reflex response in the colon that
causes it to retain the stool. |
Constipation in Crohn's
disease is usually a symptom of obstruction in the small intestine. |
Abdominal Symptoms |
Pain is not prominent symptom, but can vary. May
cause vague discomfort in the lower abdomen, an ache around the top of the
hipbone, or cramps in the middle of the abdomen. Severe pain can occur during
flare-ups. Vomiting and nausea. |
Main symptom is recurrent episodes of pain in the
lower right part of the abdomen or above the pubic bone. Often preceded by
and relieved by defecation. Bloating, nausea, and vomiting may also occur.
Intestinal pain may also be an indication of a serious condition, such as an
abscess, or a perforation of the intestinal wall. |
Fever |
May occur with severe attacks. |
Usually low-grade. Spiking fever and chills
indicates complications. |
Loss of appetite, weight loss, and impaired growth
in children |
Often not evident in mild or even moderately severe
UC. Occasionally impairs growth in children and teenagers. |
Common. Typical weight loss is 10 - 20% of normal.
Commonly impairs growth in children and teenagers. |
Abnormal defecation: Increased frequency, a feeling
of incomplete evacuation, and tenesmus (a painful
urge for a bowel movement even if the rectum is empty). Fecal
incontinence. |
Symptoms may be mild or severe. |
Can occur in active stages. |
Anal ulcers and fistulas: (channels that can burrow
between organs, loops of the intestine, or between the intestines and skin). |
Almost never a symptom. |
Fistulas and ulcers around the anus may be early
symptoms. |
Neurologic or psychiatric symptoms. |
No. |
May be early signs of Crohn's
disease when accompanied by gastrointestinal problems. |
Note:
A 2001 study reporting that early symptoms (called a prodrome)
may appear in Crohn's disease, starting about 7 years
before the full-blown symptoms occur. The prodrome
symptoms included bloating, diarrhea, stomach pain,
fever, weight loss, and fatigue. The prodromal period in ulcerous colitis is
much shorter (about a year).
Celiac disease
Celiac disease is defined as a
genetic disorder associated with malnutrition where a person is unable to
digest foods which contain the protein gluten, more specifically things that
are made from wheat, rye, barely and oats. Though the
research of this disease has only recently become popular, the accepted belief
is that it is a purely genetic disease that can be triggered by a number of
things. This disease often goes undiagnosed because it is so easily mistaken
for various other diseases due to the common symptoms. Almost all of the
complications and symptoms that arise from this are due to the body's inability
to absorb nutrients. The only treatment for this is a gluten free diet that has
been found to be highly effective.
Celiac disease is a known disease
of the small intestine. With celiac disease, the intestine experiences an
immunological or allergic reaction. The small intestine does not absorb the
nutrients of the food digested. This leads to nutritional, vitamin and mineral
deficiencies. Diagnosing celiac disease early is very important to prevent any
critical illness.
Actuality
Celiac disease is common in
European countries, particularly in Ireland, Italy, Sweden and Austria. In
Finland, the prevalence may be as high as one in every 100 persons. While in
North America, its prevalence is one in every 3000 people. Worldwide, its
occurrence would be one in every 250 people.
Celiac disease (or celiac sprue) is an autoimmune disorder with a prevalence of
approximately 0.5 to 1 percent in the United States. It is associated with
inflammation of the mucosa of the small intestine, which may result in villous
atrophy. Celiac disease produces a variety of gastrointestinal symptoms that
can begin at almost any age. Treatment consists of removal of gluten proteins
from the diet, which improves and often eliminates the small intestine
pathology.
Pathophysiology
and Epidemiology
Gluten proteins occur
throughout our food supply and are relatively resistant to digestive enzymes.
Incomplete digestion in the upper gastrointestinal tract results in peptide
derivatives that are highly immunogenic to patients with celiac disease. In
affected patients, after absorption in the small intestine these proteins
interact with the antigen-presenting cells in the lamina propria
causing an inflammatory reaction that targets the mucosa of the small
intestine. Rye, wheat, and barley, alone or as ingredients in many processed
foods, contain gluten and may elicit this immune response.
Two factors are involved in the
development of celiac disease—consumption of gluten proteins and genetic
predisposition. It is not completely understood how gluten sensitivity begins
or whether early exposure to gluten proteins increases the risk of sensitivity.
However, almost all patients with celiac disease express human leukocyte
antigen (HLA)-DQ2 or HLA-DQ8, which facilitate the immune response against
gluten proteins. Concordance rates of 70 to 75 percent among monozygotic twins
and 5 to 22 percent among first-degree relatives have been reported. Patients
with type 1 diabetes mellitus, Down syndrome, Turner's syndrome, or an
associated autoimmune disorder are at increased risk of celiac disease.
Celiac disease: an autoimmune response
Causes
Celiac, while genetic, can lie
dormant for a long period of time, or possibly not even become active at all.
It can be triggered through numerous means such as surgery, pregnancy,
childbirth, viral infection, or emotional stress. It does tend to become
evident in children fairly early on though which
allows for more immediate treatment. It seems to be strongly associated with
specific HLA genes that result in an immune reaction causing the body to attack
itself (autoimmune). This leads to malabsorption of nutrients due to the
inflammation and damage of the villi in the intestine (the organs that are
responsible for the absorption of the nutrients which are consumed). This is
shown in the image below.
Risk Factors for
Celiac Disease
Risk factor |
% |
Dermatitis herpetiformis |
100 |
First-degree relative with celiac disease |
5 to 22 |
Autoimmune thyroid disease |
1.5 to 14 |
Down syndrome |
5 to 12 |
Turner's syndrome |
2 to 10 |
Type 1 diabetes mellitus Children |
3 to 8 |
Adults |
2 to 5 |
Clinical Diagnosis
Symptoms
Digestive symptoms are more common in
infants and young children and may include
ü abdominal bloating and pain
ü chronic diarrhea
ü vomiting
ü constipation
ü pale, foul-smelling, or fatty stool
ü weight loss
ü protruding abdomen
Most commonly the symptoms begin
in children under the age of one, though like stated before they can appear
much later in life due to stressors. Almost every symptom is a result of
malabsorption; in fact malabsorption is the only symptom of celiac itself. The
classic and most immediately noticeable symptoms of celiac disease are, not
surprisingly, gastrointestinal: bloating, flatulence, and diarrhea,
with smelly stools. The symptoms which become evident include short stature, anemia, weight loss, vomiting, poor appetite, protruding
abdomen, gas, bone pain, behaviour changes, muscle cramps, fatigue, joint pain,
seizures, numbness in legs, aphthous ulcers,
dermatitis herpertiformis, tooth discoloration, and
missed menstrual period.
Many patients with celiac
disease have diarrhea, borborygmus,
abdominal pain, and weight loss. However, the disease can affect several organ
systems, including the skin, liver, nervous system, bones, reproductive system,
and endocrine system. Dermatitis herpetiformis, a
pathognomonic skin eruption, occurs in 10 to 20 percent of patients with celiac
disease.
Signs and Symptoms
of Celiac Disease
Sign or
symptom |
Prevalence
in patients with celiac disease (%) |
Common |
|
Diarrhea |
45 to 85 |
Fatigue |
78 to 80 |
Borborygmus |
35 to 72 |
Abdominal pain |
34
to 64 |
Weight loss |
45 |
Abdominal distention |
33 |
Flatulence |
28 |
Uncommon or rare |
|
Osteopenia or osteoporosis |
1 to 34 |
Abnormal liver function |
2 to 19 |
Vomiting |
5 to 16 |
Iron-deficiency anemia |
10
to 15 |
Neurologic dysfunction |
8 to 14 |
Constipation |
3 to 12 |
Nausea |
4 |
Dermatitis herpetiformis
Clinical presentation of celiac disease
Infants
and young children present with diarrhea, abdominal distension
and failure to thrive. However, vomiting, irritability, anorexia and
constipation are also common. Older children often present with
extra-intestinal manifestations, such as short stature, neurologic symptoms or anemia.
Differential Diagnosis of Celiac Disease
Anorexia
nervosa
Autoimmune
enteropathy
Bacterial
overgrowth
Collagenous
sprue
Crohn's disease
Giardiasis
Human
immunodeficiency virus enteropathy
Hypogammaglobulinemia
Infective
gastroenteritis
Intestinal
lymphoma
Irritable
bowel syndrome
Ischemic
enteritis
Lactose
intolerance
Other
immunodeficiency states
Soy
protein intolerance
Tropical
sprue
Tuberculosis
Whipple's
disease
Zollinger-Ellison
syndrome
SEROLOGY
The most common serologic
markers used for celiac disease screening are serum immunoglobulin A (IgA) endomysial antibodies and IgA tissue transglutaminase
(tTG) antibodies. Testing for gliadin
antibodies is no longer recommended because of the low sensitivity and
specificity for celiac disease. Most studies have found the sensitivity and
specificity of testing for IgA endomysial and tTG antibodies to be greater than 95 percent. However the
sensitivity depends on the degree of mucosal involvement. In addition, because tTG is the autoantigen recognized
by the endomysial antibody, there is rarely a need to
perform both tests.16 The tTG
antibody test is less costly because it uses an enzyme-linked immunosorbent assay; it is the recommended single serologic
test for celiac disease screening in the primary care setting.
American
Gastroenterological Association Institute
Recommendations for Celiac Disease Screening
Consider
testing in symptomatic patients at high risk for celiac disease with any of the
following conditions:
·
Autoimmune hepatitis
·
Down syndrome
·
Premature onset of osteoporosis
·
Primary biliary cirrhosis
·
Unexplained elevations in liver
transaminase levels
·
Unexplained iron deficiency anemia
Test
selectively as part of the medical evaluation when symptoms could be secondary
to celiac disease:
·
Autoimmune thyroid disease
·
Cerebellar ataxia
·
First- or second-degree relative with
celiac disease
·
Irritable bowel syndrome
·
Peripheral neuropathy
·
Recurrent migraine
·
Selective immunoglobulin A deficiency
·
Short stature (in children)
·
Sjgren's
syndrome
·
Turner's syndrome
·
Type 1 diabetes mellitus
·
Unexplained delayed puberty
·
Unexplained recurrent fetal loss
SMALL BOWEL BIOPSY
Despite the advent of
clinically accurate serologies, a small bowel biopsy
is required to confirm the diagnosis of celiac disease for most patients.
Biopsy should also be considered in patients with negative serologic test
results who are at high risk or in whom the physician strongly suspects celiac
disease.
However,
the mucosal changes may vary from partial to total villous atrophy, or may be
characterized by subtle crypt lengthening or increased epithelial lymphocytes.
Furthermore, these changes may be patchy, and mucosal abnormalities on
intestinal biopsy may be missed. Variations in the severity of pathologic
changes on biopsy may obscure the typical changes found in celiac disease, and
patients with latent celiac disease may have normal results on small bowel
biopsy. Therefore, to avoid false-negative results on endoscopic biopsy, most
authorities recommend obtaining at least four tissue samples, which increases
the sensitivity of the test.
Endoscopic and biopsy findings in patients with
and without celiac disease
(A)
High-definition endoscopic photo of normal small intestine. The villi are
clearly visible with no evidence of atrophy or scalloping of the folds.
(B)
Biopsy specimen of normal small intestine (hematoxylineosin;
original magnification, x 100).
(C)
Pill-Cam image of small intestine in a patient with celiac disease, showing
scalloping of the mucosal folds (arrows) characteristic of a malabsorption
pattern. There is also evidence of villous atrophy compared with normal.
(D)
Biopsy specimen of small intestine in a patient with celiac disease (hematoxylineosin; original magnification, x 100). Note
the loss of villous architecture.
CAPSULE ENDOSCOPY
The biopsy is neither 100 percent
sensitive nor specific for celiac disease; other clinical entities, such as
infection (e.g., giardiasis, human immunodeficiency virus infection),
enteritis, bacterial overgrowth, autoimmune enteropathy,
or lymphoma, may have a similar appearance. Capsule endoscopy in this setting
may be helpful to distinguish lesions in the jejunum or ileum beyond the reach
of the standard endoscope if the diagnosis is in question.
Treatment
Treatment of celiac disease is
based on avoidance of food products that contain gluten proteins. It is
essential that the diagnosis of celiac disease be confirmed before submitting
patients to this therapy. Key elements to successful treatment include the
motivation of the patient, the attentiveness of the physician to comorbidities
that need to be addressed, and the assistance of a dietitian
with expertise in gluten-free diets.
THE GLUTEN-FREE DIET
Wheat,
rye, and barley are the basic grain elements that must be avoided. The role of
oats is controversial. Although they provide an excellent source of nutrients
and fiber, most commercial products are contaminated
with other grains, and only a purified source can be used. The widespread use
of glutens in food processing requires patients to pay close attention to
labels. Table 6 lists common foods that contain gluten and those that are
gluten free.
Gluten Content of Some
Common Foods
Category |
Contains gluten |
Usually gluten free |
Breads, cereals, rice, and pasta |
Bread or pasta made from barley, bran, gluten flour,
graham flour, oat bran,* rye, wheat-based semolina, spelt, wheat, or wheat
germ Cereals made with wheat, rye, barley, or oats, or
with malt extract or malt flavorings |
Bread, cereals, or pasta made from arrowroot corn,
buckwheat, corn, cornmeal, hominy, millet, potato starch, rice, rice bran,
sago, soy, or tapioca Puffed corn Rice (brown or white); rice noodles |
Vegetables and beans |
Creamed or breaded vegetables; some French fries Canned baked beans |
Plain, fresh, frozen, or canned vegetables Soybeans |
Fruits |
Some commercial fruit pie fillings and dried fruit |
All fruits |
Dairy |
Malted milk; some milk drinks and flavored or frozen yogurt |
Milk and milk products that do not contain gluten
additives |
Meat, poultry, fish, shellfish, eggs, and nuts |
Any prepared with barley, oats, rye, wheat, or
gluten stabilizers or fillers, including some cold cuts, frankfurters,
sandwich spreads, sausages, and canned meats |
Plain meat, poultry, fish, and shellfish Cold cuts, frankfurters, sandwich spreads, and
sausages that do not contain gluten fillers Eggs; nuts and peanut butter |
Snacks and condiments |
Many commercial salad dressings, prepared soups,
condiments, and sauces |
Butter and margarine Honey; jam and jelly; molasses; sugar Coconut; hard candy; marshmallows; meringue; plain
chocolate |
Beverages |
Flavored
instant coffees; herbal teas Hot cocoa mixes; nondairy
cream substitutes |
Pure instant or ground coffee; tea Carbonated drinks; fruit juices |
*—
Pure oats are usually well tolerated but patients
should be cautioned that oat products are frequently contaminated with gluten
during processing.
Note:
This is not a complete list. Patients should read food labels to confirm that
food is gluten free. Patients should also check with their pharmacists because
some medications contain gluten.
COMPLICATIONS
Celiac disease is linked with
increased mortality. This is primarily because of the risk of malignancy; in
particular, non-Hodgkin's lymphoma, which is three to six times more likely in
patients with celiac disease. Patients with celiac disease are also at
increased risk of oropharyngeal, esophageal, and
small intestinal adenocarcinoma. The specific cause of increased malignancy
risk is not known; however, several studies support the role of a gluten-free diet
in reducing the risk of cancer.
Follow-up
Long-term follow-up of patients with
celiac disease is recommended. Serologic markers may be used to monitor
compliance with a gluten-free diet. Antibody levels typically return to normal
within three to 12 months of starting a gluten-free diet. Lack of response may
suggest continued exposure to dietary gluten, which is often inadvertent, and
patients should have further dietary instruction to ensure proper compliance
with a gluten-free diet.
Most patients who make
appropriate dietary changes will improve. If the patient does not respond as
expected despite adherence to a gluten-free diet, the physician should consider
diseases that may mimic celiac disease, such as microscopic colitis, pancreatic
insufficiency, inflammatory bowel disease, ulcerative jejunoileitis,
collagenous sprue, and T-cell lymphoma.
A repeat small bowel biopsy three to
four months after initiation of a gluten-free diet is not necessary if the
patient responds appropriately to therapy. Gluten rechallenge
with subsequent small bowel biopsy is no longer recommended. If the diagnosis
remains uncertain, or if the response to therapy is
not adequate, further diagnostic testing for other diseases should be
performed. The natural history of untreated asymptomatic disease has not been
delineated.
Referens:
A - Basic:
1.
Pediatrics. Textbook. / O. V. Tiazhka, T. V. Pochinok, A. N.
Antoshkina et al. / edited by O. Tiazhka
– Vinnytsia : Nova Knyha
Publishers, 2011 – 584 pp. : il.ISBN
978-966-382-355-3
2.
Nelson Textbook of Pediatrics, 19th Edition Kliegman, Behrman. Published by Jenson
& Stanton, 2011, 2608. ISBN: 978-080-892-420-3.
3.
Illustrated Textbook of Paediatrics, 4th
Edition. Published by Lissauer
& Clayden, 2012, 552 p. ISBN: 978-072-343-566-2.
4.
Denial Bernstein. Pediatrics
for medical Students. – Second edition, 2012. – 650 p.